CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA
Clinical trials for CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA trials appear
Sign up with your email to follow new studies for CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial hopes to halt scarring hair loss
Disease control Recruiting nowThis study tests a daily pill called deucravacitinib for two types of scarring hair loss (CCCA and FFA). About 20 adults with moderate-to-severe hair loss will take the drug for 48 weeks. The goal is to see if it reduces inflammation and scarring in the scalp.
Matched conditions: CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
Could a Light-Up cap help stop scarring hair loss?
Symptom relief Recruiting nowThis small study tests a red LED cap in 5 women with central centrifugal cicatricial alopecia (CCCA), a scarring hair loss that mainly affects middle-aged Black women. The cap uses light therapy to reduce inflammation and may help ease scalp symptoms, slow hair loss, and possibly…
Matched conditions: CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 26, 2026 05:57 UTC